Home / Uncategorized / NEWS: Berlin Cures announces start of Phase 2a for its DNA-based neutralizer of ß1-adrenoceptor autoantibodies

NEWS: Berlin Cures announces start of Phase 2a for its DNA-based neutralizer of ß1-adrenoceptor autoantibodies

Top